About Molzym

Ever since its foundation in 2003, Molzym has been committed to innovative solutions for biological research and diagnosis of infectious diseases. Our developmental efforts are particularly focused on new processes enabling and facilitating the molecular diagnosis of diseases caused by bacteria and fungi.

MolYsis, are dedicated to the targeted isolation of pathogen DNA from a variety of clinical samples, including blood culture, whole blood, CSF, BAL, joint aspirates, tissues and other operated material. Ultra-pure, DNA-free PCR reagents and mastermixes allow for the precise detection and monitoring of infectious diseases in humans and animal models.

The latest development, SelectNA™, is an instrument for the automated extraction of pathogen DNA from whole blood. SelectNA™ combines highest technical advances with demands for contamination-free and low-hands-on processing of samples for highest detection sensitivity of pathogens.

Further, Molzym is always open to any collaboration directed to the development of individualized, pre-analytic and analytic adaptations, including automated DNA isolation.

The Molzym team appreciates your interest and is at your disposal for further information about our products and developmental issues at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or call at: +49(0)421-696162-0.